Low-Glycemic (LGI) Diet in Pregnant People With Epilepsy
1 other identifier
interventional
21
1 country
1
Brief Summary
The goal of this clinical trial is to learn about the low glycemic index diet in pregnant people with epilepsy. The main questions it aims to answer are:
- Is the low glycemic index tolerable in pregnant people with epilepsy?
- Does the low glycemic index alter seizure frequency in pregnant people with epilepsy?
- Does the low glycemic index alter the gut bacteria \& associated metabolic pathways in pregnant people with epilepsy? Participants will start the low glycemic index diet during pregnancy and will provide stool and blood samples a maximum of 3 times during study duration. Researchers will compare pregnant people with epilepsy on the diet to pregnant people with epilepsy not on a structured diet plan to see if tolerability, seizure frequency, and gut bacteria composition \& metabolites differ.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2023
CompletedStudy Start
First participant enrolled
December 15, 2023
CompletedFirst Posted
Study publicly available on registry
December 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedDecember 18, 2023
December 1, 2023
1.9 years
October 27, 2023
December 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tolerability of the low glycemic index diet in pregnant people with epilepsy
Tolerability will be measured by the number of participants able to continue the diet in pregnancy with diet questionnaires + dietician follow up visits.
During the diet intervention and immediately after the diet intervention
Secondary Outcomes (3)
Seizure Frequency
Baseline pre-intervention, during the intervention, and through 3 months post-partum.
Gut Bacteria Composition
During the intervention until 3 months postpartum
Metabolic pathway alterations
During the intervention until 3 months postpartum
Study Arms (2)
Low Glycemic Index Diet Group
EXPERIMENTALA low glycemic index diet will be started with ongoing dietician support \& food questionnaires until pregnancy completion.
Standard Diet Group
NO INTERVENTIONA standard diet, as chosen by participants, will be followed with ongoing food questionnaires until pregnancy completion.
Interventions
A low glycemic diet will be initiated with dietician support and guidance.
Eligibility Criteria
You may qualify if:
- Diagnosis of focal or generalized epilepsy as defined by the International League Against Epilepsy
- Pregnant up to 20 weeks gestational age
You may not qualify if:
- Functional neurologic disorder
- Primary gastrointestinal disease
- Antibiotic use in past 3 months
- Diabetes
- Seizure freedom
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- Epilepsy Foundationcollaborator
Study Sites (1)
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Instructor of Neurology, Division of Epilepsy
Study Record Dates
First Submitted
October 27, 2023
First Posted
December 18, 2023
Study Start
December 15, 2023
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
December 18, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share